at about 58:20 YF talks about a cholangiocarcinoma trial that is at phase 2 (is he referring to the FDA ODD, I can't recall this being announced?) and explains why they are going down this path - all very interesting and promising.
IMU Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
